نتایج جستجو برای: ret ptc rearrangements

تعداد نتایج: 22926  

2015
Dagmara Rusinek Michal Swierniak Ewa Chmielik Monika Kowal Malgorzata Kowalska Renata Cyplinska Agnieszka Czarniecka Wojciech Piglowski Joanna Korfanty Mykola Chekan Jolanta Krajewska Sylwia Szpak-Ulczok Michal Jarzab Wieslawa Widlak Barbara Jarzab Paula Soares

BACKGROUND The molecular mechanisms driving the papillary thyroid carcinoma (PTC) are still poorly understood. The most frequent genetic alteration in PTC is the BRAFV600E mutation--its impact may extend even beyond PTC genomic profile and influence the tumor characteristics and even clinical behavior. METHODS In order to identify BRAF-dependent signature of early carcinogenesis in PTC, a tra...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1998
I Bongarzone P Vigneri L Mariani P Collini S Pilotti M A Pierotti

The papillary carcinoma family (PCF) of thyroid tumors includes a wide variety of neoplastic entities regarded as well-differentiated, poorly differentiated, and undifferentiated papillary thyroid carcinomas. Recent studies have established the presence of alternative oncogenic rearrangements of the RET and NTRK1 genes in a consistent fraction (< or = 50%) of papillary thyroid tumors. RET oncog...

Journal: :The Journal of clinical endocrinology and metabolism 2009
Marco Volante Ida Rapa Manoj Gandhi Gianni Bussolati Daniela Giachino Mauro Papotti Yuri E Nikiforov

CONTEXT Poorly differentiated carcinomas represent an aggressive group of thyroid tumors with controversial classification placement and poorly understood pathogenesis. Molecular data in this group of tumors are extremely heterogeneous, possibly reflecting different inclusion criteria. Recently homogeneous diagnostic criteria have been proposed by our group (Turin proposal) that need to be comp...

2013
Anna Guerra Vincenzo Di Crescenzo Alfredo Garzi Mariapia Cinelli Chiara Carlomagno Massimo Tonacchera Pio Zeppa Mario Vitale

BACKGROUND Anaplastic thyroid cancer (ATC) is a rare, lethal disease associated with a median survival of 6 months despite the best multidisciplinary care. Surgical resection is not curative in ATC patients, being often a palliative procedure. Multidisciplinary care may include surgery, loco-regional radiotherapy, and systemic therapy. Besides conventional chemotherapy, multi kinase-targeted in...

Journal: :Cancer research 2003
Edna T Kimura Marina N Nikiforova Zhaowen Zhu Jeffrey A Knauf Yuri E Nikiforov James A Fagin

Thyroid papillary cancers (PTCs) are associated with activating mutations of genes coding for RET or TRK tyrosine kinase receptors, as well as of RAS genes. Activating mutations of BRAF were reported recently in most melanomas and a small proportion of colorectal tumors. Here we show that a somatic mutation of BRAF, V599E, is the most common genetic change in PTCs (28 of 78; 35.8%). BRAF(V599E)...

2017
Dong Yang Chuanjiang Wang Yingwei Luo Xuan Li Qingbin Song Jian Zhang Shijie Xin

Disruption of Wnt signaling often happens in tumorigenesis, but whether Wnt signaling affects the early stages of thyroid tumor, such as papillary thyroid carcinoma, is still a question, especially in the papillary thyroid carcinoma without genomic RET/PTC mutation. In this study, we demonstrated the important function of Wnt signaling in papillary thyroid carcinoma K1 cells, which have no RET/...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Samuel A Wells Massimo Santoro

The RET (rearranged during transfection) protooncogene encodes a single pass transmembrane receptor that is expressed in cells derived from the neural crest and the urogenital tract. As part of a cell-surface complex, RET binds glial derived neurotrophic factor (GDNF) ligands in conjunction with GDNF-family alpha co-receptors (GFRalpha). Ligand-induced activation induces dimerization and tyrosi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید